Pancreatic Cancer Research

ResearcherUniversity of VirginiaNo recent work listed

Turan Tufan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3954-5326; OpenAlex author ID A5015752289. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

  1. ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer. Co-author DOI 10.1016/j.devcel.2022.04.014↗
  2. ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer Co-author DOI 10.1101/2020.05.23.112839↗
  3. CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response. Co-author DOI 10.1038/s41467-018-06676-2↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mazhar Adli · 3 shared papers, 2018–2022 · strength 0.28
  2. Todd W. Bauer · 3 shared papers, 2018–2022 · strength 0.28
  3. Nabeel M. Bardeesy · 2 shared papers, 2020–2022 · strength 0.21
  4. Sarbajeet Nagdas · 2 shared papers, 2020–2022 · strength 0.21
  5. David Tsai Ting · 1 shared paper, 2022 · strength 0.12
  6. William L. Hwang · 1 shared paper, 2022 · strength 0.12
  7. David F. Kashatus · 1 shared paper, 2022 · strength 0.12
  8. Harun Öztürk · 1 shared paper, 2022 · strength 0.12
  9. Alex D. Michaels · 1 shared paper, 2018 · strength 0.07
  10. Karol A. Szlachta · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.